A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
Synonyms: beta, Trastuzumab, 0, Herceptin, Trastuzumab-qyyp, Trastuzumab beta, Trazimera, P188ANX8CK, Trastuzumab, Trastuzumab qyyp
Instance information
comment
2016; TRASTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015 ,2016 (1998)
identifier
D000068878